Una historia resumida. La inhibición de la PCSK9 y su desarrollo clínicoHypercholesterolaemia is one of the major cardiovascular risk factors; however, conventional treatment with diet, exercise and cholesterol-lowering drugs are insufficient to control low-density lipoprotein (LDL) cholesterol in a...